Sarecycline, a novel and tetracycline-derived antibiotic, is being developed for use as an oral once daily antibiotic treatment for patients suffering from moderate to severe acne vulgaris. Sarecycline has anti-inflammatory activity and the potential for a favorable tolerability profile.

1035979-44-2

C24H30ClN3O8

523.97

WC3035;Sarecycline HCl;WC-3035;P 005672;WC 3035;P005672;P-005672;Sarecycline hydrochloride

H2O:Insoluble
DMSO:Soluble
Powder: -20°C for 3 years
In solvent: -80°C for 2 years